Respondents also occasionally listed commercial interests among the drivers of stratified medicine. Only in Finland and Israel did this appear to be a prominent concern, however, while one Chinese respondent anticipated rather different benefits in the form of a move towards introducing elements of a market economy into healthcare. Thus, while respondents were able to cite occasional examples of successful stratification of medical interventions - haematological cancers in Finland and lung cancer in Luxembourg, for instance - these were predominantly local examples, both geographically and in terms of being confined to a few, quite specific conditions, while the general view among respondents was that it was still too early to look for significant improvements in healthcare attributable to stratified medicine.